Our results highlight the non-enzymatic role of PSAT1 in regulating metabolic reprogramming in tumor cells harboring the p53-72Pro variant and provide a potential therapeutic strategy for cancer patients with this variant. This evidence concerns the gene PSAT1 and neoplasm.